Disease Info Card

Hermanski-pudlak Syndrome

Information about Hermanski-pudlak Syndrome: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Hermanski-pudlak Syndrome

Most recent studies have shown that Hermanski-pudlak Syndrome shares some biological mechanisms with albinism, albinism-oculocutaneous, bleeding-tendency, blood-platelet-disorders, chediak-higashi-syndrome, colitis, crohns-disease-of-large-bowel, fibrosis, hemorrhage, hemorrhagic-disorders, hereditary-diseases, hypopigmentation-disorder, hypopigmentation-immunodeficiency-disease, inflammation, lung-diseases, nystagmus, platelet-storage-pool-deficiency, pneumonia, pneumonia-interstitial, pulmonary-fibrosis.

Among the many pathways, these few ones have gauged particular interests from scientists studying Hermanski-pudlak Syndrome, and have been seen in publications frequently: Chemotaxis, Coagulation, Endosomal Transport, Excretion, Exocytosis, Eye Pigmentation, Hemostasis, Localization, Macrophage Activation, Membrane Fusion, Pathogenesis, Pigment Accumulation, Pigmentation, Platelet Activation, Platelet Aggregation, Prenylation, Secretion, Secretion Of Lysosomal Enzymes, Serotonin Uptake, Transport

Quite a number of genes have been found to play important roles in Hermanski-pudlak Syndrome, such as AP3B1, BLOC1S1, BLOC1S6, CD63, CTLA4, HLA-DQA1, HOXD13, HPS1, HPS3, HPS4, HPS5, LYST, NOD2, OCA2, TYR, TYRP1. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.